FCM
PRPH

FourWorld Capital Management’s ProPhase Labs PRPH Stock Holding History

FourWorld Capital Management’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-37,658
Closed -$152K – 28
2025
Q1 		$152K Buy
+37,658
New +$173K 0.1% 21

Other funds holding PRPH

SC
Sykon Capital Harrison, New York $300M AUM 16.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CD
Chapin Davis Baltimore, Maryland $569M AUM 145.59% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

FourWorld Capital Management's PRPH Position: Q2 2025 in Review

FourWorld Capital Management sold out of ProPhase Labs (PRPH) in Q2 2025, closing a stake of 37,658 shares — an estimated $152K sold.

FourWorld Capital Management first reported a position in PRPH in Q1 2025 and held it in 1 quarter. The position peaked at $152K in Q1 2025. 33 funds tracked by Wall St. Rank hold PRPH as of Q2 2025.

  • FourWorld Capital Management reported no remaining ProPhase Labs position as of Q2 2025 after selling out during the quarter.
  • FourWorld Capital Management sold 37,658 ProPhase Labs shares in Q2 2025, an estimated $152K.
  • FourWorld Capital Management first reported a position in ProPhase Labs in Q1 2025 and held it in 1 quarter.
  • FourWorld Capital Management's ProPhase Labs position peaked at $152K in Q1 2025.
  • 33 funds tracked by Wall St. Rank held ProPhase Labs as of Q2 2025.

Based on FourWorld Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.